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Astrocytes persistently infected with HIV-1 can transmit virus to CD4+ cells, suggesting that astrocytes may be a source of viral persistence
and dissemination in the brain. In the present study, we investigated the fate of HIV-1 upon infection of astrocytes. HIV-1 was observed in vesicle-
like structures. Unspliced genomic RNA and extrachromosomal HIV-1 DNA were detected in astrocytes, with levels declining over time. The
extrachromosomal viral DNA was not de novo reverse transcribed in astrocytes but most likely the products of intravirion reverse transcription
present in the virus inoculum. Integrated HIV-1 DNAwas not detected in assays sensitive to detect 2 integrated copies of provirus. However, the
majority of astrocyte cultures released infectious virus that could be transmitted to CD4+ cells. Our findings suggest a novel pathway of HIV-1
uptake and release in astrocytes that does not necessarily require virus replication, which may contribute to persistence and spread of HIV-1 in the
brain.
© 2005 Elsevier Inc. All rights reserved.Keywords: HIV-1; Astrocyte; Reservoir; Persistence; Latency; ReplicationIntroduction
Human immunodeficiency virus type 1 (HIV-1) invades the
central nervous system (CNS), and productively infects brain
macrophages and microglia. A subpopulation of infected
astrocytes is also consistently detected in vivo by sensitive
techniques that detect viral DNA or RNA (An et al., 1999;
Nuovo et al., 1994; Takahashi et al., 1996; Thompson et al.,
2004; Wiley, 1996), but there is no evidence of structural viral
proteins synthesized by these infected cells (Brack-Werner,
1999; Gorry et al., 2003; Messam and Major, 2000). In addition,
astrocyte infection by HIV-1 in vitro yields little progeny virus.⁎ Corresponding authors. Macfarlane Burnet Institute for Medical Research
and Public Health, GPO Box 2284, Melbourne 3001, Victoria, Australia. Fax:
+61 3 9282 2100.
E-mail addresses: jclarke@burnet.edu.au (J.N. Clarke),
stevew@burnet.edu.au (S.L. Wesselingh).
0042-6822/$ - see front matter © 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.12.004However, approximately 40% of astrocytes that harbor HIV-1
DNA in vivo also express detectable levels of early, multiply
spliced HIV-1 gene products (Bagasra et al., 1996; Brack-
Werner, 1999), in particular Nef (Blumberg et al., 1994; Ranki
et al., 1995; Saito et al., 1994; Tornatore et al., 1994a). Thus,
astrocyte infection by HIV-1 is restricted whereby multiply
spliced HIV-1 mRNA may be selectively expressed without
completion of the virus replication cycle.
Most previous studies on HIV-1 replication in astrocytes
have focused on the transcriptional control of stably integrated
HIV-1 in long-term or latently infected cells. During this
dormant phase that follows the initial infection, restricted
expression of virus results from low-level basal long-terminal
repeat (LTR) activity which can be modestly induced by
cytokines or other chemical stimuli (Shahabuddin et al., 1992;
Swingler et al., 1992). In contrast, during acute-phase
replication in astrocytes, low-level virus production appears to
be controlled post-transcriptionally, since high levels of HIV-1
142 J.N. Clarke et al. / Virology 348 (2006) 141–155mRNA are synthesized after transfection with proviral plasmid
(Gorry et al., 1998, 1999; Tornatore et al., 1994b). These
observations suggest that there may be 2 phases of entry into the
restricted state, one operating initially to suppress virion
production despite high level RNA synthesis and another that
eventually suppresses RNA transcription.
Studies examining the molecular events that restrict acute
HIV-1 production in primary astrocyte cultures and astrocytoma
cell lines have revealed that virus replication is restricted at
multiple steps of the virus life cycle (reviewed in Brack-Werner,
1999; Gorry et al., 2003; Messam and Major, 2000). HIV-1
infection of astrocytes is CD4 and coreceptor independent
(Sabri et al., 1999), and entry is a significant bottleneck to a
fully productive infection in astrocytes, as indicated by studies
that achieved a productive infection by infecting astrocytes with
virus pseudotyped with the envelope glycoproteins (Env) of
vesicular stomatitis virus (VSV) or murine leukemia virus
(MLV) (Canki et al., 2001; Schweighardt and Atwood, 2001).
Other studies have identified a cellular block in Rev function
that resulted in impaired nucleocytoplasmic transport of Rev-
dependent, unspliced and singly spliced HIV-1 mRNA (Ludwig
et al., 1999; Neumann et al., 1995), resulting in their eventual
degradation or completion of splicing. This block in Rev
function can be partially alleviated by increasing the expression
of Sam68, a 68-kDa Src-associated protein, suggesting a role
for Sam68 in the restricted astrocyte infection (Li et al., 2002).
Other post entry blocks that contribute to the restricted astrocyte
infection are those exerted on translation of HIV-1 mRNA
(Gorry et al., 1998, 1999). In these studies, translation of HIV-1
mRNA was found to be inefficient in astrocytes due to a
heightened protein kinase R (PKR)-mediated antiviral response
due to low levels of the TAR-RNA binding protein (TRBP)
(Gorry et al., 2003; Ong et al., 2005) which is a potent inhibitor
of PKR activation (Bannwarth et al., 2001; Ong et al., 2005).
When stimulated with proinflammatory cytokines TNFα or
IL1-β, or when cocultured with CD4+ cells, infected astrocytes
release infectious HIV-1 (Cheng-Mayer et al., 1987; Lawrence
et al., 2004; Sabri et al., 1999; Tornatore et al., 1991, 1994b).
This suggests that given the appropriate stimuli in vivo,
astrocytes may serve as an ongoing supply of HIV-1 in theFig. 1. Supernatant p24 profile of astrocyte infection. The culture supernatants of HIV
times post infection. Experiment A shows the typical profile over the first 4 dpi ( ; me
which either (i) untreated (●; n = 3), IL-1β treated (▴; n = 6) or cocultured with HuT-7
A ( ) and B (×) is indicated.brain. While the percentage of infected astrocytes in vivo is
relatively low (approximately 2.6%), they are the most
abundant cell type in the brain (approximately 0.4–2.0×1012
cells), and hence, numerically, they may represent a significant
source of viral persistence (Brack-Werner, 1999; Pierson et al.,
2000).
This study focuses on the entry and early post-entry events of
the HIV-1 replication cycle in astrocytes. Unlike most of the
previous studies that have bypassed HIV-1 entry in astrocytes
via transfection with proviral HIV-1 plasmid or viral pseudo-
typing with the Env of VSV or MLV, in the present study, we
infected multiple astrocytoma cell lines with cell-free HIV-1.
Consistent with the results of recent studies, we observed uptake
of HIV-1 into vesicle-like compartments (Liu et al., 2004).
Upon enhancing HIV-1 adsorption via spinoculation, we
demonstrate that HIV-1 can be subsequently released and
transmitted to CD4+ cells without necessarily undergoing
reverse transcription and integration. The results of our study
suggest that an additional pathway of nonproductive HIV-1
infection may exist in astrocytes. We propose that this pathway
may be a mechanism by which astrocytes harbor and
disseminate HIV-1 in the brain.
Results
Profile of p24 release by infected astrocytes
Following HIV-1 infection, U251-MG astrocytes were
characterized for their ability to harbor and transmit HIV-1 to
CD4+ cells by monitoring supernatant p24 levels during
infection and after coculture with target cells. To measure the
amount of virus that persisted from the viral inoculum, U251-
MG supernatants were sampled at 3 and 18 h post-infection
(hpi), prior to secretion of de novo synthesized p24 protein, and
found to contain approximately 100 pg/ml p24 (Fig. 1). After 18
hpi, the level of supernatant p24 declined with time and was
typically undetectable (b6 pg/ml) by 3 or 4 days post-infection
(dpi). At 7 dpi, infection of the astrocyte cells was demonstrated
by the recovery of virus replication upon coculture with CD4+
HuT-78 cells or by p24 release upon stimulation with IL-1β-1 NL4-3-infected astrocytes were sampled for HIV-1 p24 content at designated
an of two cultures), and Experiment B shows the profile from individual cultures
8 cells (▪; n = 2). The p24 content of the virus inoculum/culture for Experiments
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in the release of p24 in some but not all of the astrocyte cultures.
Together, these results demonstrate an initial non-productive
infection of astrocytes, activation of virus release by cytokine
stimulation and transmission of infectious virus from astrocytes
to CD4+ cells.
Entry of HIV-1 into astrocytes
To better understand the mode of entry of HIV-1 into
astrocytes, the cells were analyzed within the first hour of
infection by immunofluorescence and electron microscopy.
Infected U251-MG, CCF-STTG1 and U87-MG astrocytes
demonstrated discrete punctate staining with pooled sera from
AIDS patients in the cytoplasm at 45 min post-infection (mpi)
(Figs. 2Ai, iv). Excitation of the fluorophores used to detect
HIV-1 immunoreactivity required a relatively high intensity of
the laser beam with relatively high gain settings, as the amount
of target antigen (internalized virus) was in low abundance.
Uninfected controls (Figs. 2Aiii, vi) and infected astrocytes
treated with normal human sera (Figs. 2Aii, v) did not exhibit
punctate staining, although a low level of diffuse background
fluorescence was sometimes observed due to the high level of
laser excitation used and possibly also due to the use of human
sera on human cells. The punctate staining which appeared
beyond the main body of the cells (visible by the diffuse
background/autofluorescence) was observed to only occur
where cell projections (characteristic of U251 and CCF-
STTG1 cells) were present, as observed by light microscopy.
The punctate staining was found to be intracellular by serial
optical Z-sectioning for each cell line, and Hoechst staining of
the nuclei confirmed that the punctate staining was within the
cytoplasm (data not shown). A similar staining pattern was
observed when U251-MG cells were stained with a monoclonal
antibody to HIV-1 p24 protein at 45 mpi (Fig. 2Avii) but was
not observed in negative controls (Figs. 2Aviii, ix). These data
suggest that HIV-1 proteins are internalized in vesicle-like
compartments.
To determine whether the astrocyte internalization of HIV-1
was occurring via clathrin-mediated endocytosis, as has been
shown for the uptake of HIV-1 by CD4 negative HeLa cells
(Schaeffer et al., 2001), infections were performed in the
presence of fluorescently labeled human transferrin. Consis-
tent with previous studies (Marechal et al., 1998; Schaeffer
et al., 2001), HeLa cells exhibited discrete punctate
cytoplasmic staining for HIV-1 which colocalized with trans-
ferrin (Fig. 2Bvii), suggesting virus uptake occurred by clathrin-
mediated endocytosis. The discrete punctate HIV-1 staining in
U251-MG astrocytes was not dissimilar to that observed in HeLa
cells, however, in U251-MG cells, the punctate HIV-1
immunoreactivity did not appear to colocalize with transferrin
(Fig. 2Biii), suggesting that a different process of viral uptake
was occurring in these astrocytes.
To identify the type of vesicles that may be involved in virus
uptake by U251-MG astrocytes, cells were examined by
electron microscopy at 45 mpi. Several virion-like structures
were observed in a ring formation (Fig. 3), consistent withvirions lining the inside membrane of a vesicle. The size of the
outer margin of this ring was approximately 400×600 nm.
Concordant with mature, enveloped HIV-1 virions, the virus-
like structures exhibited an outer electron dense circumference
of approximately 100-nm diameter containing a dense cone-
shaped core. No similar structures were seen in uninfected
U251-MG cells. Occasional virus-like particles were observed
to be associated with the cell surface of infected cells. Clathrin-
coated pits were also observed, but virus-like particles were not
observed to be associated with these. The size of the vesicle-like
structure observed harboring virions was too large to represent
either clathrin- or caveolin-mediated endocytosis (Sieczkarski
and Whittaker, 2002). Rather, this morphology is consistent
with either a phagosome or a macropinosome (Sieczkarski and
Whittaker, 2002).
Analysis of HIV-1 reverse transcription in astrocytes
The ability of the infected astrocytes to transmit infection to
CD4+ cells after coculture suggested that viral replication might
be occurring within the astrocytes. We therefore next examined
viral reverse transcription in U251-MG astrocytes at various
times post-infection. HIV-1 DNA was detectable in the
extrachromosomal DNA fraction as early as 3 hpi (Fig. 4A).
The amount of extended minus strand HIV-1 then declined with
time from between 50 and 250 copies/2500 cells at 3 hpi to
approximately 10 copies/2500 cells at 48 hpi. Complete reverse
transcribed HIV-1 DNA was detected at a low level in some
cultures but was undetectable in other cultures (Fig. 4A).
To determine whether the HIV-1 DNA represented de novo
reverse transcribed DNA or input DNA from the viral inoculum,
the same experiments were performed in the presence of the
reverse transcriptase inhibitors, 3TC and AZT. In experiments
with 3TC, approximately 2 copies of extended minus strand
HIV DNA per 2500 U251-MG cells were detected at 26 hpi,
regardless of the presence or absence of 3TC throughout the
infection (Fig. 4B). As a control, the same concentration of 3TC
was confirmed to inhibit de novo reverse transcription of HIV-1
in infected HuT-78 cells (Fig. 4B). The detection of HIV-1 DNA
in U251-MG astrocytes was also found to be independent of
pre-treatment with AZT (data not shown). Similarly, extended
minus strand HIV-1 DNAwas also detectable in infected CCF-
STTG1 and U87-MG astrocytes and was independent of 3TC
(data not shown). These data suggest that the viral inoculum
may be the source of HIV-1 DNA present in infected astrocytes,
despite pre-treatment of virus stocks with DNase.
To test this hypothesis, the effectiveness of the DNase
treatment was examined. Although the virus stocks were
clarified, DNA (including β−globin DNA) from the virus
producing cells was readily detected in untreated virus stocks
(data not shown). The pNL4-3 plasmid DNA used to generate
virus stocks was shown to be susceptible to DNase treatment
(results not shown). DNase treatment of the virus stocks
effectively degraded the cellular DNA, since β−globin DNA in
DNase-treated stocks was no longer detectable using PCR
followed by Southern blot, with a sensitivity of 2 cell
equivalents of β-globin DNA at 25 cycles of PCR (Fig. 4C).
Fig. 2. Confocal microscopy analysis of intracellular HIV-1 immunoreactivity after exposure of astrocytes to HIV-1. Astrocyte cells were infected with HIV-1 NL4-3
for 45 min at 37 °C, then washed, fixed and stained for HIV-1 by immunofluorescence using either pooled Aids Patient Sera (Ai, iv) or a monoclonal antibody to HIV-1
p24 (Avii). Infected cells were also treated with normal sera or isotype control, respectively (Aii, v, vii). Uninfected cells were also treated with pooled Aids Patient
Sera or isotype control, respectively (Aiii, vi, ix). Labeled transferrin (red fluorescence) was included during some infections (B) to concurrently track clathrin-
mediated endocytosis. HeLa cells were included as a control for colocalization of internalized HIV-1 and transferrin. Immunofluorescent images were captured at 600×
magnification with a BioRad Radiance 2100 confocal microscope. Z-sections are shown for the colocalization studies (B). The results shown are representative of 3
independent experiments. Similar results were also seen in U87-MG astrocytes.
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Fig. 3. Electron transmission microscopy of U251-MG astrocytes after exposure
to HIV-1. U251-MG astrocyte cells were infected with HIV-1 IIIB for 45 min,
washed, fixed and processed for electron microscopy. Mature enveloped virus-
like particles were observed lining a vesicle-like structure (A; thick arrows).
Occasional virus-like structures were observed associated with the surface of the
cells (arrowheads). Clathrin-coated pits were seen (thin arrow) but virus-like
structures were not seen associated with them. Enlarged view of the virion-filled
vesicle (B). No similar virion-like structures were observed in uninfected control
U251-MG cells. The image is representative of two independent experiments.
The image was taken at 20,000× magnification on a Jeol Jem-1200 EXII
Transmission Electron Microscope.
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in the virus stock, but in some stocks, at least 250 copies of
extended minus strand HIV-1 DNA persisted per 15 μl viral
stock, which was the amount used to infect 1.6×104 astrocytes
(Fig. 4C). In two out of the four virus stocks used, a lower level
of complete reverse transcribed HIV-1 DNA was also detected
(up to 2–10 copies/15 μl viral stock). The amount of extended
minus strand HIV-1 DNA in DNase-treated viral stock “c” is
more than the amount detected in the U251-MG cell culture
infected with this virus stock (2 copies/2500 cells at 26 hpi
compared to ≥38 copies in the amount of original inoculum
used for this number of cells). Similarly, the low level of
complete reverse transcribed HIV-1 DNA present in some virus
stocks could account for the detection of complete reverse
transcribed HIV-1 DNA in some of the infected astrocyte
cultures. Since we used DNase-treated virus in the infection
experiments, the HIV-1 DNA detected in the astrocyte cultures
was not loosely associated with the virus inoculum but most
likely represented the products of intravirion reverse transcrip-tion (Arts et al., 1994; Lori et al., 1992; Trono, 1992; Zhang et
al., 1993), which is reportedly resistant to DNase digestion (Arts
et al., 1994).
Rescue of infectious HIV-1 from astrocytes
The infectivity of virus released from astrocytes by IL-1β
stimulation at 7–16 dpi was examined by passage of astrocyte
supernatants in HuT-78 cells. These supernatants were inter-
mittently found to contain infectious HIV-1 (Tables 1 and 2),
and release of infectious virus from any given astrocyte culture
was sporadic over consecutive days. Mock-treated HuT-78 cells
showed no signs of infection. The majority of infected astrocyte
cultures released infectious virus into their supernatant on at
least one of the days sampled (Tables 1 and 2). In contrast to
findings with p24 release, release of infectious virus appeared to
be independent of IL-1β treatment (Tables 1 and 2). The
apparent discrepancy between the two assays may reflect the
difference in sensitivity, as theoretically as little as a single
infectious particle may be detectable in the infectivity assay,
while approximately 3×107 virus particles per ml would be
required to detect the lower limit of p24 protein (6 pg/ml) in the
ELISA. The astrocyte supernatant infectivity studies demon-
strate that, although viral reverse transcription was undetectable
in the acute phase of infection, infected astrocytes may release
infectious virus when appropriately stimulated.
Analysis of HIV-1 integration in astrocytes
To further understand the apparent lack of viral synthesis in
astrocytes despite release of infectious virus, we next examined
HIV-1 integration in astrocytes. Chromosomal DNA was
extracted from infected U251-MG astrocytes that had been
treated with or without IL-1β from 7 dpi onwards and analyzed
for the presence of HIV-1 DNA. In all infected U251-MG
chromosomal DNA samples tested (28 hpi, 7 dpi, 10 dpi, 13 dpi
and 16 dpi, n=13), integrated HIV-1 DNAwas not detected by a
nested Alu-PCR assay that has the sensitivity to detect 2
integrated proviral copies in 10,000 cells (Fig. 5A). Similarly,
chromosomal-associated HIV-1 DNAwas not detected in HIV-
1-infected astrocytes by real-time PCR that has the sensitivity to
detect 2 integrated proviral copies in 20,000 cells (Fig. 5B).
Positive controls for both assays included chromosomal DNA
extracts from cocultures of infected U251-MG cells and HuT-78
cells, and astrocyte DNA samples spiked with 10 or 4 cell
equivalents of integrated chromosomal HIV-1 DNA standard,
which all yielded positive results. These results demonstrate a
lack of detectable integrated HIV-1 DNA in the astrocyte
infections.
Analysis of unspliced and multiply spliced HIV-1 RNA
transcripts
To further characterize the nature of HIV-1 infection in
astrocytes, RNA was harvested at various times post-infection
and analyzed for unspliced and multiply spliced viral mRNAs.
Infected U251-MG cultures were found to contain a substantial
Fig. 4. Analysis of reverse transcribed HIV-1 DNA in infected astrocytes and in the viral inoculum. Extrachromosomal DNAwas extracted from HIV-1 NL4-3-infected
U251-MG astrocytes at various times post infection (A), and infections in the presence/absence of the reverse transcriptase inhibitor, 3TC (B). An estimated 50 (A) or
100 (B) cell equivalents of DNAwas subjected to PCR and Southern hybridization for mitochondrial DNA. An estimated 2500 (U251-MG) or 500 (HuT-78) cells
equivalents of DNAwere subjected to PCR and Southern hybridization for extended minus strand and complete reverse transcribed HIV-1 DNA. Each lane in panel A
represents the testing of a separate, replicate culture, and the results are representative of 3 independent experiments. The lanes in panel B represent duplicate PCRs on
each of two replicate cultures, and these results were repeated in independent experiments with U251-MG, CCF-STTG1 and U87-MG astrocytes. DNAwas extracted
from DNase-treated HIV-1 NL4-3 virus stocks and normalized to the extraction efficiency of a spiked irrelevant DNA. β-Globin, extended minus strand and complete
reverse transcribed HIV-1 DNA levels were assessed (C). Each lane indicates the amplification of DNA extracted from approximately 15 μl of viral stock (the amount
of inoculum used per 16,000 cells) and represents duplicate DNA extractions from the virus stocks. Four different HIV-1 NL4-3 virus stocks were tested (a–d).
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infection, at 3.5 hpi (Fig. 6A). This was before de novo
synthesis of viral RNA, indicating that this represented input
viral RNA. In support of this conclusion, the viral inoculum wasTable 1
Infectivity of supernatants from HIV-1 infected U251-MG cells a
dpi No IL-1β IL-1β treated from 7
Individual cultures %+ Individual cultures
8 − + − + + + 67 − − + +
9 − − − − − + 17 + − + −
10 + − − − − + 33 − − − −
11 − − + − 25
12 − + − − 25
13 − − − − 0
14 + − 50
15 − + 50
16 − + 50
a HIV-1 NL4.3 infected U251-MG astrocytes were cultured in the presence or abse
dpi, filtered, and added to HuT-78 cells with centrifugal enhancement. The HuT-7
formation and p24 secretion) over 10 subsequent days. Un-inoculated HuT-78 contro
virus in supernatant samples collected from the same culture over consecutive days. T
in the U251-MG cultures of this experiment is shown in Fig. 5B.also found to contain up to 1250 copies of unspliced HIV-1
RNA per 30 μl (Fig. 6C), which was the volume of virus used to
inoculate 30,000 cells. The amount of unspliced viral RNA
detected in infected U251-MG cultures declined with time post-dpi onwards Total
%+
%+
+ − − − + − − + 42 50
− − + − + − + − 42 33
− + + − + − + − 33 33
− − − + + + − + 50 42
− − + − + − − − 25 25
− + − − − + − − 25 17
+ + − − 50 50
+ − + − 50 50
− − − − 0 17
nce of IL-1β from 7 dpi onwards. Supernatants were collected daily from 8 to 16
8 cultures were monitored for evidence (+/−) of HIV-1 infection (by syncytia
ls showed no evidence of infection. Each column represents assays for infectious
his experiment is summarized in Table 2, and the analysis of integrated provirus
Table 2

















(Not tested) 64% (14/22) 64% (14/22) 0% (0/30)
CCF-STTG1 100% (6/6) 83% (10/12) 89% (16/18) 0% (0/20)
U87-MG 100% (6/6) 100% (12/12) 100% (18/18) 0% (0/20)
a Infected astrocytes were cultured in the presence or absence of IL-1β from 7
dpi onwards. Culture supernatants were sampled daily from 8 to 16 dpi, filtered,
and applied to HuT-78 cells with centrifugal enhancement. The Hut-78 cultures
were monitored for evidence of HIV-1 infection (by syncytia formation and p24
secretion) over 10 subsequent days. Un-inoculuated HuT-78 controls showed no
evidence of infection. The percent of cultures whose supernatant (on at least one
of the days sampled) was infectious to HuT-78 cells is shown. The number of
cultures whose samples tested positive, as a function of the total number tested,
is indicated in brackets.
b Chromosomal extracts from the same cultures, as well as cultures harvested
prior to supernatant infectivity testing (≤7 dpi), were tested for HIV-1 DNA by
R-U5 Real Time PCR. The percent of positive tests and number of positive tests
as a function of the total number is shown.
c The analysis of chromosomal associated HIV-1 DNA in the U251-MG
cultures of this experiment is shown in Fig. 5B.
d The analysis of HIV-1 RNA species in the U251-MG cultures of this
experiment is shown in Figs. 6A and B.
147J.N. Clarke et al. / Virology 348 (2006) 141–155infection over the next 7 days and was undetectable (b50
copies/12,000 cells) in 63% (17/27) of samples from 10–16 dpi
(Fig. 6A). After day 7, detection of unspliced viral RNA in
different cultures did not correlate with release of infectious
virus into the supernatant, as some cultures in which unspliced
viral RNA was detected had not released detectable infectious
virus and vice versa (Fig. 6A).
Low levels of multiply spliced HIV-1 mRNA transcripts
can be packaged, albeit inefficiently, into virions (Clever and
Parslow, 1997; Luban and Goff, 1994). Analysis of virus
stocks demonstrated the presence of nef transcripts at
approximately 10–50 copies per 30 μl (Fig. 6C). Nef
transcripts were also detectable in infected U251-MG cultures
at 3.5, 26, 52 hpi and 7 dpi at varying levels (b250 copies per
250,000 cells) (Fig. 6B). The nef transcript levels did not
decline with time post-infection from 3 hpi to 7 dpi but varied
from culture to culture (Fig. 6B). This suggests that de novo
synthesis of nef transcripts occurred in some U251-MG
cultures. Nef transcripts were detectable in 44% (12/27) of
these cultures from 10 dpi onwards and did not appear to
correlate with the release of infectious virus (Figs. 6A, B). In
some of the infected U251-MG cultures, rev and tat
transcripts were also detectable (Fig. 6B). The most obvious
template for transcription of multiply spliced transcripts is
integrated provirus. However, the inability to detect integrated
HIV-1 DNA in these cultures raises the additional possibility
that the transcription may have occurred from unintegrated
viral DNA (Liang et al., 2004; Wu and Marsh, 2003).Discussion
The aim of this study was to characterize the entry of HIV-1
into astrocytes, reverse transcription and integration of the virus
within astrocytes, and the capacity of these cells to transmit
virus upon coculture or cytokine stimulation. Vesicular uptake
of HIV-1 was observed, and subsequent release of infectious
virus was detected from the majority of infected astrocyte
cultures. The absence of newly reverse transcribed and inte-
grated HIV-1 DNA in these cells suggests that an alternative,
replication-independent pathway of HIV-1 infection and
transmission can occur in astrocytes (Fig. 7).
The cell-free infection of the three astrocyte cell lines
produced a similar profile of HIV-1 p24 in the supernatant over
time, both initially and following coculture or IL-1β treatment
(Fig. 1), as previously documented for HIV-1-infected astro-
cytes (Di Rienzo et al., 1998; Lawrence et al., 2004; Messam
and Major, 2000; Sabri et al., 1999; Tornatore et al., 1991,
1994b). A close analysis of the supernatant p24 levels prior to
the occurrence of de novo synthesis indicates that in our model,
the initial p24 detection represented release of bound virus, as
similarly suggested in a recent study of HIV-1 NL4-3-infected
progenitor derived astrocytes (Lawrence et al., 2004). This
suggests that an initial productive phase of infection is not
necessary for the establishment of a restricted astrocyte
infection (Table 3).
Immunofluorescent analysis of the astrocytes after a brief
exposure to HIV-1 demonstrated vesicular-like HIV-1
immunoreactivity within the cytoplasm in almost all cells
observed (Fig 2A). Both immunofluorescent studies and
electron microscopy indicated that virus uptake was unlikely
to be mediated by clathrin (Figs. 2B, 3). Rather, the
arrangement of internalized virus-like particles within large
vesicles was analogous to the recent electron microscopy
observations of HIV-1-infected fetal astrocytes (Liu et al.,
2004). The size of these vesicles suggests that the virus may
be internalized by macropinocytosis or phagocytosis (Siecz-
karski and Whittaker, 2002). This would be consistent with
the involvement of the mannose receptor in virus entry (Liu
et al., 2004), although additional receptors may also be
involved (Hao and Lyman, 1999; Liu et al., 2004; Ma et al.,
1994).
The detection of low levels of HIV-1 DNA in U251-MG,
CCF-STTG1 and U87-MG astrocytes post HIV-1 infection is
consistent with numerous other studies using human fetal
astrocytes and astrocyte cell lines including U251-MG and
CCF-STTG1 (Brengel-Pesce et al., 1997; Di Rienzo et al.,
1998; Keys et al., 1991; Kort, 1998; Nath et al., 1995; Sabri et
al., 1999). Our results demonstrated that HIV-1 DNA did not
arise from de novo reverse transcription after virus entry into
astrocytes but rather from the input viral inoculum even though
this had been DNase treated and the excess inoculum had been
removed by rigorous washing and trypsin treatments. This
conclusion is based on (i) the observed decline of the level of
HIV-1 DNA from 3 hpi to 48 hpi, (ii) the lack of inhibition by
reverse transcriptase inhibitors on the level of astrocyte-
associated HIV-1 DNA and (iii) the presence of HIV-1 DNA
Fig. 5. Analysis of chromosomal associated HIV-1 DNA in infected astrocytes. Chromosomal DNAwas extracted from infected U251-MG astrocytes at 28 hpi, 7, 10,
13 and 16 dpi. Cultures had been treated with or without IL-1β from 7 dpi onwards, as indicated. Chromosomal DNAwas assayed for the presence of HIV-1 DNA by
(i) modified nested Alu-PCR and Southern hybridization (A) or (ii) real-time PCR for the R-U5 region of HIV-1 DNA (B). In panel A, the samples from cultures which
released detectable p24 are indicated below the Southern blot. These p24 positive samples (▵,□) were also subjected to the modified nested Alu-PCR in the presence
of 10 (▴,▪) or 4 ( ) copies of spiked integrated chromosomal HIV-1 DNA standard. The supernatant p24 profile over days 7 to 16 post-infection from this experiment
is shown in Fig. 1. Each lane in panel A represents Alu-PCR amplification on 10,000 cell equivalents of chromosomal DNA (as determined by β-globin levels) from an
individual replicate culture (except the 28 hpi samples which represent 280 cell equivalents). The integrated HIV-1 DNA standards were also assayed in the presence of
10,000 cell equivalents of chromosomal DNA. Each lane in panel B represents real-time PCR for HIV-1 DNA on 20,000 cell equivalents of chromosomal DNA from a
replicate infected U251-MG culture. HIV-1 chromosomal-integrated DNA standards were also assayed in the presence of 20,000 cell equivalents of chromosomal
DNA. The cultures for this experiment were also assessed for release of infectious virus (Table 1). A subset of chromosomal DNA samples from both ±IL-1β treated
cultures (▵,○,□,⋄) which had repeatedly demonstrated release of infectious virus (refer Table 1) were spiked with 4 copies of integrated chromosomal HIV-1 DNA
standard (▴, ●, ▪, ♦). The results are representative of independent experiments with U251-MG, CCF-STTG1 and U87-MG astrocytes.
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with the infected astrocytes at 26 hpi (Fig. 4).
Despite no evidence of viral reverse transcription in
astrocytes within the first 48 hpi, all the infected astrocyte
cultures were capable of transmitting infectious HIV-1 to HuT-
78 cells upon coculture initiated at 7 dpi. Similar to previous
reports of transmission of infection by astrocytes upon coculture
(Cheng-Mayer et al., 1987; Di Rienzo et al., 1998; Sabri et al.,
1999), at least 2 days (and up to 6 days) of coculture was
required before HIV-1 p24 release and syncytia were detectable.
This delay could indicate that release of virus from astrocytes is
inherently inefficient, and/or the transition from restricted to
productive infection is a slow process. An additional possibility
may be that persistent surface-bound virus was transmitted upon
coculture. While this cannot be completely excluded, persis-
tence of infectious surface-bound virus is unlikely as theastrocytes were treated with trypsin, which inactivates and
removes cell-bound HIV-1 (Cheng-Mayer et al., 1987; Tang and
Levy, 1991), immediately following infection and again at 5
dpi, prior to coculture with HuT-78 cells. The absence of de
novo reverse transcription in the first 48 hpi coupled with the
apparent lag in transmission indicated that viral replication may
be restricted, prior to reverse transcription, until the occurrence
of certain events triggered by coculture or cytokine stimulus.
To assess this, astrocyte cultures that had been treated with or
without IL-1β from 7dpi onwards were analyzed for integrated
proviral DNA and release of infectious virus. The amount of
infectious virus released into the astrocyte supernatants was
exceedingly low, sporadic and independent of IL-1β treatment
(Tables 1, 2). This implied that virus release was spontaneous.
Infectious virus was detected in the supernatants of the majority
(84%, n=76) of infected U251-MGl, CCF-STTG1 and U87-
Fig. 6. Analysis of HIV-1 RNA in infected astrocytes and in the viral inoculum. Total RNAwas extracted from viral stocks and from U251-MG cells at various times
post-HIV-1 NL4-3 infection, and β−actin and viral RNA species were reverse transcribed into cDNA. Unspliced HIV-1 transcripts was assayed by HIV-1 Gag PCR
and Southern hybridization on 12,000 cell equivalents of cDNA (as determined by β-actin RT-PCR) (A). HIV-1 DNA standards were also assayed in the presence of
12,000 cell equivalents of uninfected cDNA. Each lane represents a replicate U251-MG culture. Treatment with or without IL-1β from 7 dpi onwards is indicated
above each lane. The results of the assay for infectious virus release are indicated below each lane (and summarized in Table 2 where this experiment is identified as the
repeat U251-MG experiment). The multiply spliced class of HIV-1 transcripts was detected by PCR on 250,000–350,000 cell equivalents of cDNA. This PCR, which
amplifies all HIV-1 multiply spliced RNA species, was followed by Southern hybridization with probes specific for the unique splice junction sites of tat, rev and nef
(B, C). Each lane corresponds to the same culture tested for HIV-1 Gag cDNA in panel A above. The marker lane in panel B is derived from HIV-1 NL4-3-infected
HuT-78 cells. Unspliced and multiply spliced HIV-1 RNA in the virus stocks were assayed by the same methods (C). Each lane represents a PCR input of cDNA
equating to 30 μl of virus from each of virus stocks (a, b and c), which corresponds the amount of inoculum used per 30,000 cells.
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integrated HIV-1 DNA was undetectable at a sensitivity of 2
copies/20,000 cells in all experiments (Fig. 5), suggesting that a
low level of the original virus could persist in an infectious state
and be subsequently released from the astrocytes.
The presence of HIV-1 regulatory transcripts in the astrocyte
cultures is intriguing, as HIV-1 regulatory protein expression, in
particular Nef, has been reported in both in vivo and in vitro
astrocyte infections (Blumberg et al., 1994; Brack-Werner et al.,
1992; Kort, 1998; Neumann et al., 1995; Ranki et al., 1995;
Saito et al., 1994; Tornatore et al., 1994a, 1994b). Transcription
of nef in some of the cultures could suggest that a restricted
infection had occurred in a subpopulation of cells in a subset of
cultures. Although possible, in this study, this appears unlikelyas (i) nef expression did not correlate with cultures which
released of infectious virus, and (ii) integrated provirus was
undetectable in these cultures with high assay sensitivity and a
large number of cultures tested. Therefore, an alternate
explanation is that the nef transcripts could have originated
from unintegrated viral nucleic acid in the inoculum (Liang et
al., 2004; Wu and Marsh, 2003).
Aside from the curious expression of nef, our findings
suggest that a replication-independent pathway of HIV-1
infection and transmission occurred in astrocytes. The absence
of a restricted-productive infection and the apparent discrepan-
cy compared to other astrocyte infection paradigms may relate
to the infection method used. Of note, this study involved
exposure of astrocytes to HIV-1 with wild-type envelope, in the
Fig. 7. Multiple pathways of HIV-1 infection of astrocytes. Our results, taken
together with previous models of astrocyte infection, indicate that at least two
pathways for HIV-1 infection and transmission from astrocytes may exist. (A)
The previously proposed pathway involving restricted virus replication. In
astrocytes, this is hampered by several cell-specific restrictions to HIV-1
replication but may go to completion in certain astrocyte subpopulations or
stages of differentiation, with certain strains of HIV-1 or upon coculture/
cytokine stimulus. (B) Virus uptake with later release in the absence of
replication, as supported by results of the present study. HIV-1 enters the
astrocyte by phagocytosis/macropinocytosis. The virions have 3 potential fates:
(i) escape into the cytoplasm (Fackler and Peterlin, 2000) which may permit
access into the conventional pathway, (ii) lysosome-mediated degradation
(Fackler and Peterlin, 2000; Schaeffer et al., 2001), or, as indicated by the
present study, (iii) preservation of the integrity of the virus with subsequent virus
release without viral replication.
Table 3
Comparison of astrocyte infection ±IL-1β treatment and CD4+ cell coculture










p24 release (after 7 dpi) − ± +++
Syncytia − − +++
Integrated HIV-1 DNA − − +++
Release of infectious virus + + +++
a Astrocyte cells cultured in the presence of 10U/ml IL-1β from 7 dpi
onwards.
b Astrocyte cells cocultured with HuT-78 cells from 7 dpi onwards.
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often used to enhance virus–cell interactions by interfering with
the electrostatic charge on the cell surface. However, to improve
the efficiency of infection, we employed a spinoculation
protocol on astrocyte cells that had been trypsinized prior to
virus exposure. The release of infectious virions, in the absence
of evidence of replication, from the spinoculated astrocytes
(which were subsequently treated to remove surface-bound
virions) suggests that some virions from the initial inoculum can
persist in an intact, unfused state in an intracellular compartment
and be subsequently released. The E.M. and confocal
microscopy analyses, while performed on pre-seeded astrocytes
(in order to maintain the morphology of the cells), indicate that
the concept of uptake and persistence of intact, enveloped
virions in intracellular vesicles is plausible. Comparison of thevirus replication data from our trypsin pre-treated astrocytes to
previous studies suggests that restricted-productive infection of
astrocytes may proceed through a receptor(s) that may be
susceptible to cleavage by trypsin. In our model, the treatment
of the cells with trypsin prior to infection revealed an additional,
replication-independent pathway of infection, which may have
otherwise have been masked by restricted-productive infection.
It is worth noting that the mannose receptor, the only identified
receptor for HIV-1 on astrocytes to date (Liu et al., 2004), is
reportedly resistant to trypsin (Turville et al., 2004).
Cellular uptake of HIV-1 and subsequent transmission of
infection without replication have been previously described in
dendritic cells (“trans-infection”) (Turville et al., 2003, 2004)
and epithelial and trophoblast cells (“transcytosis”) (Bomsel,
1997; Lagaye et al., 2001). Astrocytes have been reported to
perform transcytosis (Megias et al., 2000; Tabernero et al.,
2002), phagocytosis (Shrikant and Benveniste, 1996) and
possibly macropinocytosis as evidenced by membrane ruffling
observations in U87-MG astrocytes upon exposure to virus (Liu
et al., 2004). The replication-independent transmission of
infection described in the present study, taken together with
previous models of astrocyte infection, supports the notion that
multiple pathways of HIV-1/cell interaction may occur in
astrocytes within the brain microenvironment (Fig. 7). One
previously proposed pathway in astrocytes gives rise to low,
inducible virus production. An additional pathway which may
exist in some types of astrocytes, supported by data in this
paper, involves virus uptake and transmission without the virus
replicating.
Infectious HIV-1 has been recovered from astrocytes as long
as 4 or 5 months post-infection (Chiodi et al., 1987; Dewhurst et
al., 1987). The possibility that astrocytes in the CNS may harbor
and transmit virus without replication may represent an
important mechanism by which HIV-1 may evade anti-
retroviral therapy. This non-replicative mode of HIV-1
persistence and transmission may also be important in the
entry and spread of HIV-1 in the CNS. This novel mode of
virus/astrocyte interaction may also represent an additional way
in which HIV-1 can disrupt normal astrocyte function, as
interplay between the virus and intracellular vesicle sorting
events could alter the normal astrocyte vesicle sorting events
151J.N. Clarke et al. / Virology 348 (2006) 141–155required for recycling of neurotransmitters and export of
neurotropic factors. Further understanding of non-replicative
astrocyte infection will be important for a comprehensive
understanding HIV-1 entry, spread and persistence in the CNS
as well as for understanding the mechanisms by which HIV-1
induces astrocyte dysfunction and apoptosis, and the subse-




U251-MG astrocytoma cells (kindly provided by Dr. D
Purcell) and HeLa cells (obtained from the American Type
Culture Collection ATCC) were cultured in Dulbecco's
modified Eagle Medium (DMEM) (Gibco BRL) supplemen-
ted with 10% (vol/vol) fetal calf serum (FCS), 10 mM
HEPES, 44 mM sodium bicarbonate, 2 mM L-glutamine, 1.2
μg/ml penicillin and 1.6 μg/ml gentamicin. CCF-STTG1
astrocytoma cells were obtained from the ATCC and
cultured in RPMI 1640 medium (Gibco BRL) supplemented
with 10% (vol/vol) FCS, 18 mM sodium bicarbonate, 10
mM HEPES, 2 mM L-glutamine, 1 mM Sodium Pyruvate,
25 mM glucose, 1.2 μg/ml penicillin, and 1.6 μg/ml
gentamicin. U87-MG glioma cells, also obtained from the
ATCC, were cultured in Eagles minimum essential medium
(EMEM) (Gibco BRL) with Earles Basal Salt Solution
(BSS) (Gibco BRL) supplemented with 10% (vol/vol) FCS,
18 mM sodium bicarbonate, 2 mM L-glutamine, 0.1 mM
non-essential amino acids, 1.2 μg/ml penicillin and 1.6 μg/
ml gentamicin. These three well-characterized astrocytoma
cell lines were chosen for this study to ensure that the
cultures represented a pure population. A pure astrocytic
population was essential to the highly sensitive assays for
integrated proviral DNA and virus release. Fetal astrocyte
preparations were not used as it would be difficult to
completely exclude the presence of any microglial cells, in
which HIV-1 might replicate.
The lymphoblastoid cell lines HuT-78 and CEM-SS were
obtained from the AIDS Research and Reference Reagent
Program, NIH. HuT-78 and CEM-SS cells were cultured in
RPMI 1640 (Gibco BRL) supplemented with 10% (vol/vol)
FCS, 20 mM HEPES, 14 mM sodium bicarbonate, 2 mM
L-glutamine, 1.2 μg/ml penicillin and 1.6 μg/ml gentamicin.
HIV-1 virus stocks
HIV-1 NL4-3 virus stock was prepared by transfection of
293 T cells with proviral plasmid and expanded in CEM-SS
cells. Virus produced in CEM-SS cell supernatants was
filtered through 0.2 μm filters and stored at −80 °C. Virus
stocks were treated with 50 μg/ml DNase 1 (Roche) in the
presence of 10 mM MgCl2 for 30 min at room temperature.
HIV-1 IIIB virus stock was prepared as described previously
(Vandegraaff et al., 2001) and concentrated by centrifugation
in a 15 ml Amicon Ultra 100,000 MWCO (Millipore)column. HIV-1 NL4-3 and IIIB virus stocks were quantified
by measuring TCID50 in CEM-SS and HuT78 cells,
respectively, and by HIV-1 p24 concentration (Perkin Elmer
Life Sciences).
Immunofluorescence and confocal microscopy
Cells were cultured on glass coverslips overnight to reach
80–90% confluence, then infected with HIV-1 NL4-3 virus for
15, 30, 45, 60 or 75 min at 37 °C. In some experiments,
AlexaFluor546-conjugated human transferrin (Molecular
Probes) was included at a final concentration of 25 μg/ml
during the infection. For controls, uninfected cells were
examined in parallel, and control antibodies or sera were used
on infected cells. Cells were fixed in 1% (vol/vol) formalin/PBS
overnight at 4 °C, rinsed in 80% (vol/vol) ethanol, washed by
serial PBS submersion, permeabilized with 0.05% (vol/vol)
IPEGAL CA-630 (Sigma)/PBS for 20–30 min, washed with
PBS and blocked with 2% (vol/vol) normal goat serum (NGS)/
PBS for 30–45 min. The cells were then incubated with the
respective primary antibody combinations in 2% (vol/vol) NGS/
PBS for 60–90 min. HIV-1 staining was achieved using pooled
AIDS patient sera (1/1000) or murine monoclonal anti HIV-1
p24 IgG1κ (1/100). GFAP was visualized using rabbit anti-
human GFAP polyclonal antibody (Zymed) (1/50). Following
washing, the cells were incubated with the secondary antibodies
in 2% (vol/vol) NGS/PBS for 60–75 min. Cyanine2-conjugated
donkey anti-human IgG1 (1/100) (Jackson ImmunoResearch
Laboratories) or AlexaFluor488-conjugated goat anti-human
IgG1 (1/200) (Molecular Probes) were used to detect bound
human IgG. AlexaFluor546-conjugated goat anti-mouse IgG1
(1/200) (Molecular Probes) was used to detect bound murine
IgG1. Cyanine3-conjugated anti-rabbit IgG1 (1/100) (Jackson
ImmunoResearch Laboratories) or AlexaFluor488-conjugated
goat anti-rabbit IgG1 (1/200) was used to detect bound rabbit
antibodies. After subsequent washes, the nuclei of the cells
were counterstained with 5 μg/ml Hoechst 33342 (Molecular
Probes)/PBS for 15–20 min. Cells were washed again before
being mounted onto glass slides with ProLong AntiFade
Mounting Medium (Molecular Probes), allowed to dry,
sealed and stored in the dark at 4 °C until examined by
confocal microscopy.
Confocal images were captured at 600× magnification using
a BioRad Radiance 2100 confocal microscope. Identical laser
and microscope settings were used for experimental and control
cells. Image data were analyzed with Confocal Assistant
software program for the Microsoft Windows (Todd Clark
Brelje, USA) and converted to CMYK tiff files by the
Photography Department, Institute of Medical and Veterinary
Science, Adelaide.
Electron microscopy
Cell culture chamber slides were seeded with U251-MG
cells and cultured overnight to reach 80–90% confluence. The
cells were infected for 45 min at 37 °C by replacing half of the
culture medium with concentrated HIV-1 IIIB virus stock, after
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three times with PBS, fixed in 2.5% (v/v) glutaraldehyde in
sodium cacodylate buffer overnight at 4 °C. Cells were post-
fixed in 2% (v/v) osmium tetroxide and embedded in
Spurr's Epoxy Resin. Ultra-thin sections were cut and
stained with uranyl acetate and lead citrate. Uninfected
controls were prepared simultaneously. Sections were
analyzed with a Jeol Jem-1200 EXII transmission electron
microscope.
HIV-1 infection of astrocytes and post-infection analysis
Infections were performed with a modified centrifugal
enhancement protocol (Ho et al., 1993; Li and Burrell, 1992;
Pietroboni et al., 1989; Vandegraaff et al., 2001). Briefly,
astrocytes were dislodged from cell monolayers by incubation
with 0.1% (vol/vol) trypsin for 5 min at 37 °C and
subsequently suspended in DNase-treated viral stocks at 0.1–
0.3 TCID50U/cell (0.4–1.2 pg p24/cell) for 30 min at 4 °C in
teflon tubes, followed by centrifugation at 2500 × g at 37 °C
for 60 min. The cells were washed three times in complete
medium, twice in serum-free medium, incubated in 0.05% (vol/
vol) trypsin for 5 min and washed twice again with complete
medium. Washes were performed at room temperature with
pre-warmed medium. A proportion of the cells were harvested
for analysis of HIV-1 DNA and RNA for 3 h post-infection
(hpi), and the remainder was seeded into 6-well cell culture
dishes at a density of 4×105 cells per well. p24 release into the
supernatant was assayed throughout the course of the infection
by p24 ELISA. At 5 days post-infection (dpi), the remaining
cultures were rinsed with PBS, treated with trypsin (0.1% vol/
vol for 3–5 min or until all the cells were detached), and the
cells were resuspended in complete medium, pooled and
reseeded into 3× as many fresh wells. To test for virus
transmission from these cultures, the cells were either
cocultured with 1×106 HuT-78 cells (commencing 7dpi) or
treated with 10 U/ml IL-1β (Roche) (commencing 7dpi).
Untreated cultures were also maintained as controls. HuT-78
cocultures were analyzed over the subsequent 6 days by
measuring supernatant p24 levels and syncytia formation. IL-
1β treatment was maintained by daily 0.5 volume media
changes for the remainder of the experiment (until 16dpi).
Supernatants from cultures ± IL-1β treatment were assayed for
infectious virus and p24 protein (ELISA).
DNA extraction
HIRT pellet (chromosomal) and HIRT supernatant (extra-
chromosomal) DNA extractions were performed as originally
described (Hirt, 1967) in the presence of 0.5 mg/ml proteinase K
(Merck). DNA preparations were resuspended in water and
stored at −80 °C.
Virus stock samples with or without DNase treatment were
spiked with equivalent amounts of plasmid DNA (pGEM-
DengueCapsid) to enable subsequent normalization of the DNA
extraction efficiency. Total DNA was then prepared as for the
HIRT supernatant DNA extractions.Analysis of HIV-1 reverse transcription
Infections were carried out in the presence or absence of
the reverse transcriptase nucleoside analogues zidovudine
(AZT) (Sigma) and lamivudine (3TC) (a kind gift from David
Bourke, Victorian College of Pharmacy, Australia). Cells were
pre-incubated with the drug or DMSO overnight prior to the
infection. AZT and 3TC were maintained at a concentration
of 20 μM and 50 μM, respectively, throughout the infection
until the cells were harvested for extrachromosomal DNA
extraction at 3, 26 or 48 hpi. Infected HuT-78 cells were
included as controls. The mitochondrial DNA content of the
extrachromosomal DNA samples was assessed by semi-
quantitative PCR followed by Southern blot. These DNA
samples were then analyzed for various sequential DNA
products of HIV-1 reverse transcription, using semi-quantita-
tive PCR followed by Southern blot targeting the extended
minus strand (extended post first strand transfer) and the
complete reverse transcribed HIV-1 DNA (extended post
second strand transfer). The gag region of the HIV-1 genome
was used to specifically target extended minus strand, and all
subsequent HIV-1 reverse transcripts (see Conventional PCR
procedures section for primer sequences, amplification and
detection parameters). Primers which spanned the U3 to gag
region of the HIV-1 genome were used to specifically target
complete reverse transcripts (refer Conventional PCR proce-
dures section for primer sequences, amplification and
detection parameters, and refer to Karageorgos et al. (1995)
for the correlation of these primer binding sites with the stage
of reverse transcription (Karageorgos et al., 1995)). DNA
extracts from virus stocks were similarly analyzed for these
intermediates of HIV-1 reverse transcription.
Analysis of HIV-1 integration
Chromosomal DNA extracted from cultures harvested at 1,
2, 7, 10, 13 and 16 dpi were normalized according to β-
globin DNA content. HIV integration was assayed either by
Alu-PCR followed by Southern blot (Kumar et al., 2002;
Vandegraaff et al., 2001) or by real-time HIV-1 R-U5 PCR.
Ten microliters real-time PCR reactions were prepared with
Quantitect SYBER Green (Qiagen) 1× PCR mix (MgCl2 and
dNTPs included), 1 pmol each primer (HPLC purified) and
respective sample DNA. For β−globin, the same primer sequences
were used as published previously (Vandegraaff et al., 2001). For
detection of HIV-1 DNA in cellular chromosomal DNA
preparations (R-U5 PCR), the primers SS1 and SS2a were
used. SS1 (5′-CTA ACT AGG GAA CCC ACT GC-3′) binds
to the HIV-1 genome in the R region of the LTR (sequence
coordinates nt 498–517 in HIV-1 NL4-3, Gene Bank accession
numberM19921) and SS2a (5′-CTG CTA GAG ATT TTC CAC
AC-3′) binds in the U5 region of the LTR (sequence coordinates
nt 635-616 in HIV-1 NL4-3, Gene Bank accession number
M19921). PCRs were performed in a Rotor-Gene machine
(Corgette Research), and subsequent analyses were performed
with Rotor-Gene software cycler (Corgette Research) and
Microsoft Excel.
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RNAwas extracted from infected cells at designated times as
described previously (Chomczynski and Sacchi, 1987). The
RNA precipitate was resuspended in 1.0 U/μl RNase free
DNase (Roche), 0.4 U/μl RNase Inhibitor (Roche), 0.1 M
sodium acetate, 5 mM MgSO4, pH 5.0 and incubated for 120
min at room temperature, then re-extracted and resuspended in
deionized water with 0.4 U/μl RNase inhibitor. cDNA was
prepared immediately with 0.8 U/μl RT-AMV (Roche), 0.4U/μl
RNase Inhibitor (Roche), 1 pmol/ml each 3′ primer (ba2,
adx2JC, gagHIII), 1 mM each dNTP (Promega) in 1× AMV RT
buffer (Roche) incubated at 42 °C for 50 min, followed by RT
AMV inactivation at 95 °C and storage at −20 °C. cDNA
samples were analyzed by PCR followed by Southern
hybridization as described below.
Copy number standards
HA8 DNA standards, derived from three persistently HIV-1-
infected cell lines and representing 4 different sites of HIV-1
integration, were used to calibrate all HIV-1 DNA and β−globin
PCRs and have been described previously (Vandegraaff et al.,
2001). For extrachromosomal DNA extractions, samples were
quantified according to their mitochondrial DNA content by
comparison to extrachromosomal DNA from a known number
of cells of the same cell line. HuT-78 cells were found to contain
approximately 5× more mitochondrial DNA/cell than U251-
MG cells (data not shown).
cDNA samples were normalized according to their level of
β-actin cDNA by comparison to β-actin cDNA levels from a
known number of cells of the same cell line.
For HIV-1 tat, rev and nef cDNA standards, tat, rev and nef
fragments were purified from plasmids encoding the respective
cDNAs as described previously (Davis et al., 1997). The
fragments were quantified by UV spectrometry and by
comparison to DNA markers of known mass by ethidium
bromide stained polyacrylamide gel electrophoresis, followed
by quantification using Typhoon 9410 (Molecular Dynamics)
fluorescence scanning and ImageQuant software (Molecular
Dynamics).
Conventional PCR procedures
Conventional PCRs were performed in a Perkin-Elmer
GeneAmp PCR 9600 system. PCRs for mitochondrial, β-globin
and extended minus strand reverse transcribed HIV-1 DNA
were performed with Amplitaq Gold DNA (Roche), an initial
denaturation of 10 min at 95 °C and then as previously
described (Vandegraaff et al., 2001), with one nucleotide
change (underlined) in the GAG-III(−) primer (5′-CTGTGA-
AGCTGGCTCGGCTC-3′) to ensure 100% sequence homolo-
gy to HIV-1 NL4-3. Amplifications targeting complete reverse
transcribed HIV-1 DNA were performed similarly but with a
primer extension time of 45 seconds, with U3.1(+) and gag3(−)
primers, which have been described previously (Karageorgos et
al., 1995).cDNA β-actin content was determined by solo amplification
of a segment of the β-actin gene with Amplitaq Gold DNA
polymerase (Roche) and an initial denaturation of 10 min at 95
°C and an annealing temperature of 60 °C but otherwise as
described previously (Davis et al., 1997). Full length genomic
HIV-1 cDNAwas amplified using GAG-P1(+) and GAG-III(−)
primers using the PCR conditions for these primers as described
previously (Vandegraaff et al., 2001) and above. HIV-1 2-kb
transcript cDNAs (tat, rev and nef) were co-amplified as
described previously (Davis et al., 1997) with adp1 and adx2
primers modified to exclude unnecessary accessory 5′
sequences (adp1JC 5′-TCT CGA CGC AGG ACT CGG CTT-
3′ and adx2JC 5′-ATT CCT TCG GGC CTG TCG GGT-3′).
Amplitaq Gold DNA polymerase (Roche) was used with an
initial denaturation of 10 min at 95 °C and an annealing
temperature of 60 °C, and other parameters were as previously
described (Davis et al., 1997).
Southern blotting
Mitochondrial, β-globin, extended minus strand, complete
reverse transcribed HIV-1 DNA and nested Alu PCR products,
and HIV-1 Gag reverse transcribed PCR products (5 μl), were
subjected to electrophoresis and Southern hybridization with
[α-32P]dATP-labeled DNA fragments and analysis as described
previously (Vandegraaff et al., 2001). The probes used for
extended minus strand and complete reverse transcribed HIV-1
DNA PCR product detection were the same as those used for
HIV-1 Gag reverse transcribed PCR and nested Alu-PCR
products, respectively.
β-Actin and multiply spliced 2kb HIV-1 transcripts (rev, tat
and nef) reverse transcribed PCR products (5 μl) were subjected
to electrophoresis and Southern hybridization with [γ-32P]
dATP-labeled DNA oligomers and quantified using Image-
Quant as described previously (Davis et al., 1997). Rev, tat and
nef cDNA splice junction probes were combined to allow
detection of all three species on the same membrane, with the
stringency of post-hybridization washes increased to 0.1×SSC,
0.1% (wt/vol) SDS at 70 °C. Membranes were then exposed to
Storage Phospor Screens (Molecular Dynamics) and subse-
quently analyzed using Typhoon 9410 (Molecular Dynamics)
phospor scanning and ImageQuant software (Molecular
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